Cargando…
Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells
Cancer is one of the most common causes of death among adults. Chemotherapy is crucial in determining patient survival and quality of life. However, the development of multidrug resistance (MDR) continues to pose a significant challenge in the management of cancer. In this study, we analyzed the rol...
Autores principales: | Russo, Annapina, Saide, Assunta, Smaldone, Silvia, Faraonio, Raffaella, Russo, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372563/ https://www.ncbi.nlm.nih.gov/pubmed/28273808 http://dx.doi.org/10.3390/ijms18030547 |
Ejemplares similares
-
rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment
por: Russo, Annapina, et al.
Publicado: (2016) -
S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells
por: Mosca, Laura, et al.
Publicado: (2020) -
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53
por: Pagliara, Valentina, et al.
Publicado: (2016) -
Role of uL3 in the Crosstalk between Nucleolar Stress and Autophagy in Colon Cancer Cells
por: Pecoraro, Annalisa, et al.
Publicado: (2020) -
Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress
por: Pecoraro, Annalisa, et al.
Publicado: (2019)